ProCE Banner Activity

Advancing Care for Patients Receiving CAR T-Cell Therapy: New Evidence and Opportunities for Oncology Pharmacy Practice

Slideset Download

Download this slideset from a local live webinar to learn how to optimally manage your patients with hematologic malignancies using CAR T-cell therapy.

Released: April 01, 2022

Expiration: March 31, 2023

No longer available for credit.

Share

Faculty

Craig Freyer

Craig Freyer, PharmD, BCOP

Clinical Pharmacy Specialist
Hematology/Oncology, Stem Cell Transplant, and Cellular Therapy
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Andrew Lin

Andrew Lin, PharmD, BCOP

Clinical Pharmacy Specialist
Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Craig Freyer, PharmD, BCOP

Clinical Pharmacy Specialist
Hematology/Oncology, Stem Cell Transplant, and Cellular Therapy
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Craig W. Freyer, PharmD, BCOP, has disclosed that he has received consultant/advisor/speaker fees from Astellas, EUSA, and Servier.

Andrew Lin, PharmD, BCOP

Clinical Pharmacy Specialist
Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, New York

Andrew Lin, PharmD, BCOP, has disclosed that he has received consultant/advisor/speaker fees from EUSA, Incyte, and Medexus.